CN2503865Y - Medicine released support - Google Patents
Medicine released support Download PDFInfo
- Publication number
- CN2503865Y CN2503865Y CN01232493U CN01232493U CN2503865Y CN 2503865 Y CN2503865 Y CN 2503865Y CN 01232493 U CN01232493 U CN 01232493U CN 01232493 U CN01232493 U CN 01232493U CN 2503865 Y CN2503865 Y CN 2503865Y
- Authority
- CN
- China
- Prior art keywords
- bare bracket
- drug
- type support
- release type
- drug release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 131
- 229940079593 drug Drugs 0.000 title claims abstract description 83
- 239000000203 mixture Substances 0.000 claims abstract description 39
- 239000000463 material Substances 0.000 claims abstract description 31
- 239000011248 coating agent Substances 0.000 claims description 47
- 238000000576 coating method Methods 0.000 claims description 47
- 229920002521 macromolecule Polymers 0.000 claims description 22
- 230000001464 adherent effect Effects 0.000 claims description 15
- 239000002184 metal Substances 0.000 claims description 14
- 238000009826 distribution Methods 0.000 claims description 13
- 229910045601 alloy Inorganic materials 0.000 claims description 9
- 239000000956 alloy Substances 0.000 claims description 9
- 238000009827 uniform distribution Methods 0.000 claims description 7
- 239000002131 composite material Substances 0.000 claims description 6
- 239000000560 biocompatible material Substances 0.000 claims description 5
- 238000009828 non-uniform distribution Methods 0.000 claims description 5
- 229910000831 Steel Inorganic materials 0.000 claims description 4
- 239000010959 steel Substances 0.000 claims description 4
- 229910001069 Ti alloy Inorganic materials 0.000 claims description 3
- 229960000074 biopharmaceutical Drugs 0.000 claims description 3
- 229910001092 metal group alloy Inorganic materials 0.000 claims description 3
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 238000013268 sustained release Methods 0.000 claims description 3
- 239000012730 sustained-release form Substances 0.000 claims description 3
- 230000002745 absorbent Effects 0.000 abstract 2
- 239000002250 absorbent Substances 0.000 abstract 2
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 7
- 239000010410 layer Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 210000003238 esophagus Anatomy 0.000 description 4
- 239000010409 thin film Substances 0.000 description 4
- 208000037803 restenosis Diseases 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 229920001710 Polyorthoester Polymers 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 150000003891 oxalate salts Chemical class 0.000 description 2
- 229920001281 polyalkylene Polymers 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- -1 Polyimino carbonates Polymers 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 229940072645 coumadin Drugs 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 238000009730 filament winding Methods 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN01232493U CN2503865Y (en) | 2001-08-01 | 2001-08-01 | Medicine released support |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN01232493U CN2503865Y (en) | 2001-08-01 | 2001-08-01 | Medicine released support |
Publications (1)
Publication Number | Publication Date |
---|---|
CN2503865Y true CN2503865Y (en) | 2002-08-07 |
Family
ID=33646534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN01232493U Expired - Lifetime CN2503865Y (en) | 2001-08-01 | 2001-08-01 | Medicine released support |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN2503865Y (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102113927A (en) * | 2009-12-30 | 2011-07-06 | 微创医疗器械(上海)有限公司 | Self-expanded stent |
CN102908171A (en) * | 2011-08-02 | 2013-02-06 | 倍捷医疗科技江苏有限公司 | Human body lumen therapeutic device |
CN103330607A (en) * | 2013-06-27 | 2013-10-02 | 河南科技大学 | Self-retracting intraesophageal bracket capable of carrying radiation elements for partial radiotherapy |
CN104352293A (en) * | 2014-11-25 | 2015-02-18 | 北京航空航天大学 | Drug eluting stent capable of reducing late thrombosis |
CN106963525A (en) * | 2012-01-27 | 2017-07-21 | 美敦力瓦斯科尔勒公司 | Hollow medicine filling bracket and the method for forming the hollow medicine filling bracket |
CN107095728A (en) * | 2017-05-19 | 2017-08-29 | 东莞颠覆产品设计有限公司 | Carried stent in tube chamber |
-
2001
- 2001-08-01 CN CN01232493U patent/CN2503865Y/en not_active Expired - Lifetime
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102113927A (en) * | 2009-12-30 | 2011-07-06 | 微创医疗器械(上海)有限公司 | Self-expanded stent |
CN102908171A (en) * | 2011-08-02 | 2013-02-06 | 倍捷医疗科技江苏有限公司 | Human body lumen therapeutic device |
CN106963525A (en) * | 2012-01-27 | 2017-07-21 | 美敦力瓦斯科尔勒公司 | Hollow medicine filling bracket and the method for forming the hollow medicine filling bracket |
CN106963525B (en) * | 2012-01-27 | 2019-12-20 | 美敦力瓦斯科尔勒公司 | Hollow drug-filled stents and methods of forming the same |
CN103330607A (en) * | 2013-06-27 | 2013-10-02 | 河南科技大学 | Self-retracting intraesophageal bracket capable of carrying radiation elements for partial radiotherapy |
CN103330607B (en) * | 2013-06-27 | 2015-07-01 | 河南科技大学 | Self-retracting intraesophageal bracket capable of carrying radiation elements for partial radiotherapy |
CN104352293A (en) * | 2014-11-25 | 2015-02-18 | 北京航空航天大学 | Drug eluting stent capable of reducing late thrombosis |
CN107095728A (en) * | 2017-05-19 | 2017-08-29 | 东莞颠覆产品设计有限公司 | Carried stent in tube chamber |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100482186C (en) | Method and apparatus for loading a benefical agent into an expandable medical device | |
ES2534934T3 (en) | Antirenstenotic drug to be used in a method with a bioabsorbable stent with deposits | |
CN200980748Y (en) | Porous medicine releasing structure for medicine eluting apparatus | |
CN1655738A (en) | Drug eluting implantable medical device | |
US20050100577A1 (en) | Expandable medical device with beneficial agent matrix formed by a multi solvent system | |
CN1812754A (en) | Polymeric stent and method of manufacture | |
CN1972723A (en) | A balloon for use in angioplasty with an outer layer of nanofibers | |
EP2289571A1 (en) | Implantable medical device with beneficial agent concentration gradient | |
AU2005201560A1 (en) | Bioresorbable stent delivery system | |
CN1684641A (en) | Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device | |
CN200980747Y (en) | Medicine releasing structure for medicine eluting apparatus | |
CN117838375A (en) | Stent assembly and method of making a stent assembly | |
JP2011156355A (en) | Differential loading of drug-eluting medical device | |
CN1812755A (en) | Stent comprising a coating system | |
CN1762330A (en) | Medicine-loading sustained-releasing nanosphere alimentary tract stent | |
CN2503865Y (en) | Medicine released support | |
CN1762331A (en) | Skeleton pattern medicine film encapsulated alimentary tract stent | |
CN101559011B (en) | Drug release tubular support provided with internal supporting wings | |
CN110575607A (en) | Medicine balloon | |
CN200980749Y (en) | Local porous medicine releasing structure with medicine used medicine eluting apparatus | |
CN106236342B (en) | Implantable complete biological absorbable vascular polymer stent | |
CN200970281Y (en) | Medicine storage and medicine releasing structure for medicinal elution device | |
CN200980750Y (en) | Medicine releasing structure with nanometer-level hole used for medicine eluting apparatus | |
CN101069660B (en) | Preparing method of biliary-tract carriage carrying about medicine | |
CN115382027B (en) | Cobalt-chromium alloy stent and drug-coated stent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING YUEPU MEDICAL APPARATUS CO. LTD. Free format text: FORMER OWNER: PU ZHONGJIE Effective date: 20040528 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20040528 Address after: 102200 Beijing City, Changping District science and Technology Park of Zhongguancun science and Technology Building 3 layer Beikong Guo Libin Patentee after: Beijing Lepu Medical Device Co., Ltd. Address before: 723001 No. 106, Chen Jiaying family building, Hanzhoung Teachers College, Hanzhoung, Shaanxi Patentee before: Pu Zhongjie |
|
C56 | Change in the name or address of the patentee |
Owner name: LE PU (BEIJING) MEDICAL DEVICES CO. Free format text: FORMER NAME OR ADDRESS: BEIJING YUEPU MEDICAL APPARATUS CO. LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Beijing City, Changping District Zhongguancun Science Park Beikong science and Technology Building 3 floor, zip code: 102200 Patentee after: Lepu (Beijing) Medical Instrument Co., Ltd. Address before: Beijing City, Changping District Zhongguancun Science Park Beikong science and Technology Building 3 floor, zip code: 102200 Patentee before: Beijing Lepu Medical Device Co., Ltd. |
|
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20110801 Granted publication date: 20020807 |